EKR Therapeutics has received FDA approval for double concentration Cardene IV (nicardipine HCl premixed injection) for the short-term treatment of hypertension when oral therapy is not feasible or desirable. Double concentration Cardene IV Ready-to-Use Bag will be available in either dextrose or sodium chloride solution in a 0.2mg/mL dosage strength.

Cardene IV is also already available in a 0.1mg/mL dosage strength as a premixed dextrose or sodium chloride solution in a Ready-to-Use Bag or as 10mL ampules for IV infusion after dilution.

For more information call (877) 207-5802 or visit www.cardeneiv.com.